RI Hospital first in country to enroll patient in new study for recurrent chest wall breast cancer
PROVIDENCE -- Rhode Island Hospital is one of only four sites across the country to participate in a new clinical trial called the DIGNITY Study. The study will investigate the effectiveness of a chemotherapeutic agent, ThermoDox, used in conjunction with mild hyperthermia (a form of heat therapy)...
Blue Cross Blue Shield of Michigan Launches Effort in Five Michigan Cities with Department of Community Health to Enroll Uninsured Children in MIChild
DETROIT, Sept. 26 /PRNewswire/ -- Blue Cross Blue Shield of Michigan is
partnering with the Michigan Department of Community Health in an effort in
five Michigan cities to help enroll
eligible uninsured children in MIChild. The Blues are hosting the meetings to urge community leaders and smal...
Armed Forces Enroll Wives in Fighting HIV/AIDS
Can an injury caused due to a syringe used on an AIDS patient infect the injured with HIV? No, it won't. Because HIV must enter your body in sufficient quantity for you to get infected . That's another reason why it is almost impossible to get infected with HIV from a barber's razor. Is it true mos...
DuPage Community Foundation Awards $15,000 Grant to Marianjoy Pediatric Continuing Care Program
... for our exceptional physical, occupational and speech therapies. They then enroll
their children into our group classes to help practice the hands-on skills,...nomy and financial difficulties have discouraged parents from being able to enroll
their children in additional programming sessions.
"We are so appre...
Arizona Pain Specialists Contend Recent Vertebroplasty Studies are Misleading: Studies Actually Show it is Effective at Reducing Pain
... the study have enough patients for the statistics to have sufficient power to detect the differences. Both studies reported that they were unable to enroll
enough patients to have reasonable statistical power. One study noted that they needed 250 patients but only enrolled 131. "The trends in the d...
Internists tackle key health reform issues
...or health reform and achieve other policy goals? If so, how should such a cap be designed and linked to other reforms?
Should the public be able to enroll
in a "public plan" offered and administered by the federal government in addition to qualified private health insurance plans? If so, how should such...
CryoLife Receives CE Mark Approval for BioFoam(R) Hemostatic Technology
...roval from the FDA to conduct the feasibility phase of the company's BioFoam IDE submission for liver parenchymal sealing. The feasibility phase will enroll
a total of 20 subjects at two investigational sites in the U.S. Before beginning this phase, the Company must receive final approval of the study pro...
Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis
...mptoms associated with rheumatoid arthritis. The study will include multiple centers in the United States and Eastern Europe. The company expects to enroll
up to 120 patients with rheumatoid arthritis on stable methotrexate therapy. Three dose levels will be evaluated: a 70 mg dose, a 110 mg dose and a ...
Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX-0401 (Perifosine) in the Treatment of Multiple Myeloma
...lled trial comparing the efficacy and safety of KRX-0401 vs. placebo when combined with bortezomib and dexamethasone. The trial, powered at 90%, will enroll
approximately 400 patients with relapsed or relapsed / refractory multiple myeloma. The primary endpoint is progression-free survival and secondary e...
AstraZeneca and the Artery Explorer Take California Residents on Virtual Journey Through the Arteries
...the Artery Explorer in person, a video is available at www.athero.com , in addition to more information about atherosclerosis and an opportunity to enroll
in the educational Athero IQ program.
Atherosclerosis is the progressive buildup of plaque -- made of fat, cholester...
Enroll in Medical Technology
InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients
TEL AVIV, Israel, May 6 /PRNewswire/ -- InspireMD, developers of
MGuard(TM), announced today that the first patient has been enrolled in the
iMOS registry. MGuard(TM) was successfully implanted at the General
University Hospital in Prague; the procedure was performed by Dr. Jan Horak.
Intercell AG Partners with Inclinix to Enroll 1800 Volunteers for Phase III Travelers' Diarrhea Vaccine Study
WILMINGTON, N.C., Jan. 19 /PRNewswire/ -- Intercell AG has retained
Inclinix, Inc., to recruit volunteers for their Phase III clinical trial of a
Travelers' Diarrhea (TD) vaccine system. The TD vaccine is in the form of a
skin patch -- a novel method for delivering a vaccine that is especiall...
Terumo Cardiovascular Systems Initiates U.S. Clinical Trial for Anaconda(TM) AAA Stent Graft System
...atients presenting with AAA when compared to historical open surgical repair. The Food and Drug Administration (FDA) has given Terumo CVS approval to enroll
180 patients at 20 sites, some of which will be in Canada. The primary endpoint for the study is the successful treatment of the aneurysm twelve mont...
World's First Cardiac Adult Stem Cell Patient Receives Infusion
...sh Hospital Heart and Lung Institute Distinguished Chair in Cardiology and Director of UofL's Institute for Molecular Cardiology said, "We continue to enroll
patients in this first-of-its-kind clinical trial. We hope to help the heart regenerate its own tissue and improve heart function." Bolli is collabora...
UPDATE: US Oncology Research Network Participates in Phase III Follow-up Study to BiPar's Investigational Cancer Drug BSI-201
...ry focus now is enrolling patients in this trial with a similar sense of urgency."
Physicians within the US Oncology network are expected to enroll
more than 100 participants in this 420-patient study. Enrollment in the study opened July 17 in centers nationwide.
"The BSI-201 PARP Inhibit...
BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
...program; that ongoing peramivir clinical trials or our peramivir program in general may not be successful; that we or our licensees may not be able to enroll
the required number of subjects in planned clinical trials of our product candidates and that such clinical trials may not be successfully completed; ...
Schering-Plough Expands Vicriviroc Phase II Study in Treatment-Naive Patients With HIV
...isk of myocardial infarction.(5-7)
About the Phase II Naive Study
This randomized, controlled, open-label study is projected to enroll
approximately 200 treatment-naive HIV-infected adult patients at more than 35 sites in North America, Central America, Europe and South Africa. Patie...
June 2009 Mayo Clinic Women's HealthSource Highlights Summer Skin Problems, Low Vision and Pilates
...ovements. Instead of emphasizing quantity, Pilates focuses on quality -- doing a few, extremely precise repetitions.
The best way to start is to enroll
in a class taught by a qualified instructor. Success with Pilates depends on precision of movement and effort. Proper instruction is key to knowing ho...
Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections
... CXA-101 as a potential treatment for serious bacterial infections in hospitalized patients.
The multi-center, randomized study is anticipated to enroll
approximately 120 patients and will compare the efficacy and safety of CXA-101 with the current standard of therapy. The primary efficacy endpoint fo...
Conatus Pharmaceuticals Initiates a Second Phase 2 Clinical Trial for the Treatment of Hepatitis
...hase 2 clinical trial with a novel drug candidate for the treatment of liver disease associated with Hepatitis C Virus (HCV) infection. The trial will enroll
patients for whom treatment with approved standard of care treatments is not currently advised. Results from an earlier clinical trial in HCV patient...
Enroll in Medical Dictionary
Infertility in women
...t risk for pregnancy loss. ... ... for a study to treat infertility in women with polycystic ovary syndrome (PCOS). The study seeks to enroll
678 women with infertility due to PCOS, who are trying ... ... the woman's fallopian tubes, which is the leading cause of female ... Both me...
Enroll in Biological News
Indonesia Now Using MegaMatcher Biometric Technology in Integrated Passport Issuance System
...rca Hardayaperkasa, to develop a distributed passport issuance system that enables the Republic of Indonesia's 100+ Immigration Offices to quickly enroll
and process local passport applications. Data from the local offices is automatically forwarded to a centralized biometric matching system that delive...
Clinical trials for shingles drug take an important step forward
...e first half of 2010.
Russell H. Plumb, president and chief executive officer of Inhibitex, Inc said: "We have more than 20 U.S sites qualified to enroll
patients, and plan to ultimately utilise a total of 50-60 sites in this trial. We believe this enthusiastic response from the clinical community refle...
Novel lung cancer vaccine shows promise in fighting early-stage lung cancer
... The MAGRIT (MAGE-A3 as Adjuvant Non-Small Cell LunG Cancer Immunotherapy) study is a randomized, double-blind and placebo controlled trial that will enroll
patients with MAGE A-3-positive, non-small-cell lung cancers. The experimental vaccine targets MAGE-A3, a protein expressed in certain cancer cells bu...
UC Davis bench-to-bedside research: Promising treatment in clinical trials
... pressure, inflammation and diabetes is very attractive."
The Phase IIa clinical trial is a double-blind, placebo-controlled study. Officials will enroll
a total of 150 patients with impaired glucose tolerance, mild obesity and mild to moderate hypertension.
Each patient will receive 28 days of trea...
Autism Speaks funds $5 million to studies on genetic and environmental risk factors for autism
...EARLI will explore possible risk factors and biological indicators for ASD during the prenatal, neonatal and early postnatal periods. The project will enroll
and follow up to 1200 mothers of children with autism at the start of a new pregnancy and document the development of their newborn siblings through a...
TGen Clinical Research Services at Scottsdale Healthcare and Mayo Clinic study new cancer drug
...l cell lung cancer the study was expanded to further investigate TH-302 anti-tumor activity in these tumors. Both Phase 1 and 1/2 trials continue to enroll
patients with other solid tumors. If successful, Phase 2 and 3 clinical trials will confirm the drug's effectiveness on solid tumors.
In cancer, a...
CIC to Host Webinar Featuring Independent Research Firm: 'Enabling Straight Through Processing - Why the Insurance Industry Needs Electronic Signature Technology'
...g insurers to move to eBusiness
How electronic signatures play a key role in the insurance industry's eBusiness strategy
for the event please Register Here
Communication Intelligence Corporation ("CIC") is a leading supplier of electronic signatur...
UNC expands brain imaging study of infants at risk for autism
...'s Hospital of Philadelphia. The project also includes a data coordinating center at the Montreal Neurological Institute in Canada.
The study will enroll
544 infants, aged 6 and 12 months, whose older siblings are autistic. At the start, they will receive behavioral assessments and magnetic resonance im...
UCSF Fresno leading-edge study lends hope to emphysema patients
... to offer this research approach soon to patients in the Central Valley.
"We are currently enrolling patients in this trial and we will continue to enroll
patients for next year," Dr. Van Gundy said. To find out more about the study you can go online www.easetrialus.com
Brown University and Women & Infants Hospital expand national children's study to Bristol County
... gynecology and community health at The Warren Alpert Medical School of Brown University.
At a national level, the National Children's Study will enroll
a representative sample of 100,000 infants and follow them from before birth to age 21. Modeled after major long-term biomedical research projects suc...
Enroll in Biological Technology
Arizona Pain Specialists Contend Recent Vertebroplasty Studies are Misleading
... the study have enough patients for the statistics to have sufficient power to detect the differences. Both studies reported that they were unable to enroll
enough patients to have reasonable statistical power. One study noted that they needed 250 patients but only enrolled 131. "The trends in the data d...
InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
...udies in rats and monkeys, respectively which clear the way for our Phase 2 and Phase 3 clinical programs; our expectation that our partner Roche will enroll
the first patient in our Phase 2b study of ITMN-191 in combination with standard of care in August; our plans to start a Phase 1b MAD study of ITMN-19...
Repligen Reports First Quarter Fiscal Year 2010 Financial Results
...diseases such as acute and chronic pancreatitis. This study is being conducted at approximately 30 clinical sites within the U.S. and Canada and will enroll
approximately 225 patients. We have made steady progress on enrollment and plan to complete this trial by the end of the year. The FDA has granted t...
Amicus Therapeutics Announces Second Quarter 2009 Financial Results
...month double-blind, randomized, placebo-controlled treatment stage and will enroll
approximately 60 subjects who are naive to enzyme replacement therapy (ERT)...idates are unsafe or ineffective; the potential that it may be difficult to enroll
patients in our clinical trials; the potential that preclinical and clinica...
Nile Therapeutics, Inc. Announces Dosing of First Patient in Phase 2 Study of CD-NP for the Treatment of Acute Heart Failure
...D-NP's ability to relieve symptoms of acute heart failure and its effects on biomarkers of heart failure and renal function. The study is expected to enroll
approximately 30 to 40 patients in the United States, Germany and Israel and will examine up to 3 doses of CD-NP.
"Currently there is a signifi...
DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD
...the upcoming confirmatory Phase 3 protocol will be a highly powered, double-blind, randomized, placebo-controlled, multi-center trial and will seek to enroll
an estimated 166 patients. The primary endpoint is the treatment failure rate at Study Day 80. This endpoint was successfully measured as a secondary ...
Oncothyreon announces presentation of long-term Stimuvax data at World Conference on Lung Cancer
...cles of platinum-based chemo-radiotherapy. The Phase 3 trial is expected to enroll
more than 1,300 patients in over 30 countries. For more information on the ...y advanced, recurrent or metastatic breast cancer. STRIDE is anticipated to enroll
more than 900 patients at approximately 180 sites in over 30 countries - in...
AEterna Zentaris Partner, Keryx, Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial with Perifosine (KRX-0401) for the Treatment of Multiple Myeloma
...led study comparing the efficacy and safety of perifosine vs. placebo when combined with bortezomib and dexamethasone. The trial, powered at 90%, will enroll
approximately 400 patients with relapsed or relapsed/refractory multiple myeloma. The primary endpoint is progression-free survival and secondary endp...
CuraGen Reports Second Quarter 2009 Financial Results
...c advisor fees of $1.5 million and $1.6 million for the three and six month periods ended June 30, 2009, respectively.
CuraGen is continuing to enroll
patients in clinical trials of CR011-vcMMAE, an antibody-drug conjugate that targets GPNMB. "We continue to be very positive about the development opp...
United States FDA Clears the REGEN Trial to Test Bioheart's Combination Gene and Stem Cell Therapy in Heart Failure Patients
...at the US FDA cleared a phase I clinical trial for MyoCell SDF-1 (Stromal Derived Factor - 1) to treat congestive heart failure. The REGEN trial will enroll
15 patients in a multicenter, randomized, dose escalation study to assess the safety and cardiovascular effects of the implantation of MyoCell SDF-1 i...